Global Glucose Monitoring Market (2020 to 2027) - Featuring Abbott Laboratories, Roche Holdings and Sinocare Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Glucose Monitoring Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering.

Glucose Monitoring consists of products that are essential for measuring glucose levels in diabetes patients. With the projected rise in the aged population and awareness about diabetes conditions, the market is focused on growing with newer technology and improved products. According to analysis, the Glucose Monitoring global market is expected to grow at a low single digit CAGR from 2020 to 2027 reach $15,321.8 million by 2027.

Factors driving the Glucose Monitoring market are the global rise in the prevalence and incidence of diabetes, increasing demand for a less minimally invasive or non-invasive and point-of-care device; increasing R&D investments are driving the market growth, whereas, the growing diffusion of smart devices and digital platforms increasing compliance and management of diabetes is creating opportunities in the coming years. The high cost of the products, frequent product recalls and inadequate reimbursement is restraining the market growth. The stringent regulations, privacy concerns and safety issues are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The product segment is divided into three segments i.e., Invasive, Non-Invasive and lab-based glucose monitoring products. The Invasive glucose monitoring products segment accounted for the largest share in 2020 due to technological advancements, easy use, and patient-friendly nature of products. Invasive products are further divided into Self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM) products. The self glucose monitoring segment accounted for the largest share in 2020 due to their relatively lower cost. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2020 due development of no coding strips. The continuous glucose monitoring market includes sensors/receivers and transmitters. The continuous glucose market includes products sensors/receivers and transmitters. The continuous glucose segment is the fastest-growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027.

Companies Mentioned

• Elektronika Kft
• A&T Corporation
• Abbott Laboratories
• Acon Diabetes Care International
• Adaltis S.R.L
• Agamatrix, Inc.
• Alliance International Co. Ltd
• Allmedicus Co. Ltd
• Ambrosia Systems, Inc
• Andon Health Co. Ltd.
• Apex Biotechnology Corp.
• Arkray, Inc.
• B. Braun Melsungen AG
• Beato Curv
• Becton Dickinson and Company
• Beijing Yicheng Bioelectronics Technology Co. Ltd.
• Beurer GmbH
• Biochemical Systems International S.P.A.
• Bioland Technology Ltd.
• Bionime Corporation
• Bioptik Ltd.
• Bio-Rad Laboratories, Inc
• Biotest Medical Corporation
• Bremed Limited
• Cambridge Sensors Ltd (Microdot)
• Chungdo Pharm. Co. Ltd
• Contec Medical Systems Co. Ltd.
• Convergent Technologies GmbH & Co. Kg
• Ctk Biotech, Inc
• Danaher Corporation(Hemocue)
• Dario Health Corp.
• And Many More Companies!

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

3.1 Introduction

3.2 Market Segmentation

3.3 Factors Influencing Market

3.3.1 Drivers and Opportunities

3.3.1.1 the Global Rise in the Prevalence and Incidence of Diabetes

3.3.1.2 Increasing Demand for Minimally or Non-Invasive and Point-Of-Care Devices.

3.3.1.3 Increasing R & D Investments

3.3.1.4 Growing Diffusion of Smart Devices and Digital Platforms Increasing Compliance and Management of Diabetes

3.3.2 Restraints and Threats

3.3.2.1 High Cost Associated With the Products

3.3.2.2 Inadequate Reimbursement

3.3.2.3 Product Recalls

3.3.2.4 Strict Regulation of Glucose Monitoring Devices by Regulatory Organizations Like the FDA and Others

3.3.2.5 Privacy Concern and Safety Issues in Connected Devices

3.4 Regulatory Affairs

3.5 Reimbursement Scenario

3.6 Patent Analysis

3.7 Technology Advancements

3.8 Product Launches and Approvals

3.9 Funding Scenario

3.10 Porter's Five Force Analysis

3.11 Market Share Analysis by Major Players

3.12 Regional Market Share Analysis

3.13 Units Sold

3.14 Market Penetration Analysis

3.15 COVID-19 Impact

4 Glucose Monitoring Global Market, by Products

5 Glucose Monitoring Global Market, by Sample Source

6 Glucose Monitoring Global Market, by End-Users

7 Regional Analysis

7.1 Introduction

7.2 North America

7.2.1 U.S.

7.2.2 Rest of North America

7.3 Europe

7.3.1 Germany

7.3.2 Italy

7.3.3 France

7.3.4 Rest of Europe

7.4 Asia - Pacific

7.4.1 Japan

7.4.2 China

7.4.3 India

7.4.4 Rest of Asia-Pacific

7.5 Rest of the World

7.5.1 Brazil

7.5.2 Middle East & Others

7.5.3 Rest of Latin America

8 Competitive Landscape

9 Major Companies

For more information about this report visit https://www.researchandmarkets.com/r/j78nf6